Ratios Uncovered: Breaking Down Ocugen Inc (OCGN)’s Trailing Twelve Months Metrics

Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.

The price of Ocugen Inc (NASDAQ: OCGN) closed at $0.83 in the last session, down -5.57% from day before closing price of $0.88. In other words, the price has decreased by -$5.57 from its previous closing price. On the day, 5.51 million shares were traded.

Ratios:

We take a closer look at OCGN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.60 and its Current Ratio is at 2.60. In the meantime, Its Debt-to-Equity ratio is 2.00 whereas as Long-Term Debt/Eq ratio is at 1.95.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 15, 2024, initiated with a Buy rating and assigned the stock a target price of $4.

On March 01, 2023, Chardan Capital Markets Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $3.50.

On August 23, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.Mizuho initiated its Buy rating on August 23, 2022, with a $5 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 26 ’24 when Fernandes Prabhavathi bought 10,000 shares for $0.91 per share. The transaction valued at 9,095 led to the insider holds 10,000 shares of the business.

Castillo Kirsten bought 25,000 shares of OCGN for $22,848 on Nov 22 ’24. The Director now owns 75,000 shares after completing the transaction at $0.91 per share. On Aug 16 ’24, another insider, RAMESH KUMAR, who serves as the Director of the company, bought 116,705 shares for $1.25 each.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 53.90 while its Price-to-Book (P/B) ratio in mrq is 15.31.

Stock Price History:

Over the past 52 weeks, OCGN has reached a high of $1.98, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is 16.22%, while the 200-Day Moving Average is calculated to be -2.87%.

Shares Statistics:

A total of 292.03M shares are outstanding, with a floating share count of 286.77M. Insiders hold about 1.80% of the company’s shares, while institutions hold 26.40% stake in the company.

Earnings Estimates

A comprehensive evaluation of Ocugen Inc (OCGN) is underway, with the input of 3.0 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.07.

Analysts are recommending an EPS of between -$0.21 and -$0.25 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is -$0.25, with 2.0 analysts recommending between -$0.22 and -$0.27.

Revenue Estimates

A total of 4 analysts have provided revenue estimates for OCGN’s current fiscal year. The highest revenue estimate was $5.6M, while the lowest revenue estimate was $1.48M, resulting in an average revenue estimate of $2.52M. In the same quarter a year ago, actual revenue was $4.05M

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.